0000899243-20-025807.txt : 20200921 0000899243-20-025807.hdr.sgml : 20200921 20200921184228 ACCESSION NUMBER: 0000899243-20-025807 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200917 FILED AS OF DATE: 20200921 DATE AS OF CHANGE: 20200921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VIRCA NICHOLAS J CENTRAL INDEX KEY: 0001284074 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13467 FILM NUMBER: 201187476 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inhibitor Therapeutics, Inc. CENTRAL INDEX KEY: 0001042418 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 541641133 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4830 W. KENNEDY BLVD. STREET 2: SUITE 600 CITY: TAMPA STATE: FL ZIP: 33609 BUSINESS PHONE: (813) 766-2462 MAIL ADDRESS: STREET 1: 4830 W. KENNEDY BLVD. STREET 2: SUITE 600 CITY: TAMPA STATE: FL ZIP: 33609 FORMER COMPANY: FORMER CONFORMED NAME: HedgePath Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20130816 FORMER COMPANY: FORMER CONFORMED NAME: COMMONWEALTH BIOTECHNOLOGIES INC DATE OF NAME CHANGE: 19970714 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-09-17 0 0001042418 Inhibitor Therapeutics, Inc. INTI 0001284074 VIRCA NICHOLAS J 4830 W. KENNEDY BLVD., SUITE 600 TAMPA FL 33609 0 1 0 0 President and CEO Common Stock Option 0.054 2020-09-17 4 A 0 100000 0.00 A 2020-09-17 2030-09-17 Common Stock 100000 100000 D /s/ Nicholas J. Virca 2020-09-21